# Pharma Manufacturing Quality PBC Manual Improvement Backlog

## Purpose

This strict backlog replaces scaffold-derived roadmap material for `pharma_manufacturing_quality` with a hand-curated regulated manufacturing quality roadmap. The PBC owns pharma batches, master batch records, validation protocols, deviations, CAPA, release, serialization, quality evidence, governed rules, agent assistance, and release evidence without owning plant maintenance, finance, EHR, or external regulatory submission systems.

## Current Domain Evidence Used

- Stable PBC key: `pharma_manufacturing_quality`.
- Domain purpose: batch records, validation, deviations, CAPA, release, serialization, and regulated manufacturing quality.
- Owned domain tables: `pharma_batch`, `master_batch_record`, `validation_protocol`, `deviation`, `capa`, `batch_release`, `serialization_event`, `pharma_manufacturing_quality_policy_rule`, `pharma_manufacturing_quality_runtime_parameter`, `pharma_manufacturing_quality_schema_extension`, `pharma_manufacturing_quality_control_assertion`, `pharma_manufacturing_quality_governed_model`.
- Public APIs: `POST /pharma-batchs`, `POST /master-batch-records`, `POST /validation-protocols`, `POST /deviations`, `POST /capas`, `GET /pharma-manufacturing-quality-workbench`.
- Emitted AppGen-X events: `PharmaManufacturingQualityCreated`, `PharmaManufacturingQualityUpdated`, `PharmaManufacturingQualityApproved`, `PharmaManufacturingQualityExceptionOpened`.
- Consumed AppGen-X events: `PolicyChanged`, `AuditEventSealed`, `OperationalKpiChanged`.

## 50 High-Impact Improvements

### 1. Master Batch Record Versioning

**Justification:** Manufacturing instructions must be controlled by product, strength, site, equipment train, process version, and effective date.

**Improvement:** Expand `master_batch_record` with version, product, process stage, approved instruction, critical parameter, hold point, effective window, and supersession reason.

**Acceptance evidence:** Tests must prove batches execute against the active approved record and preserve historical instruction versions.

### 2. Electronic Batch Record Execution

**Justification:** Batch execution needs step-by-step evidence, operator identity, timestamps, values, exceptions, and signatures.

**Improvement:** Add batch step execution with expected value, actual value, unit, performer, verifier, timestamp, exception, and e-signature meaning.

**Acceptance evidence:** Tests must prevent batch completion when required steps or signatures are missing.

### 3. Material Lot Genealogy

**Justification:** Batch quality depends on raw material, intermediate, packaging, and component lot traceability.

**Improvement:** Add material lot usage, supplier projection, certificate status, quantity, expiry, retest date, and genealogy from input to finished batch.

**Acceptance evidence:** Tests must trace affected batches from a rejected or recalled input lot without reading procurement tables.

### 4. Equipment Train Qualification Boundary

**Justification:** Equipment qualification and maintenance may be owned elsewhere, but batch quality needs trusted evidence.

**Improvement:** Store equipment qualification projection, cleaning status, calibration status, availability, and freshness as declared dependency evidence.

**Acceptance evidence:** Boundary tests must fail on maintenance table reads and pass on declared AppGen-X projection usage.

### 5. Critical Process Parameter Monitoring

**Justification:** Temperature, pressure, speed, humidity, time, pH, and weight parameters affect product quality.

**Improvement:** Add parameter definitions, acceptable range, alert/action limits, sampled value, excursion, reviewer, and batch impact.

**Acceptance evidence:** Tests must open deviations for out-of-range critical parameters and block release until impact is assessed.

### 6. In-Process Control Testing

**Justification:** Manufacturing stages often require checks before continuation.

**Improvement:** Add in-process tests, sampling point, specification, result, pass/fail, reviewer, and stage hold/release.

**Acceptance evidence:** Tests must prevent stage progression when required tests fail or are missing.

### 7. Environmental Monitoring Linkage

**Justification:** Cleanroom environmental failures can affect batch disposition.

**Improvement:** Add environmental condition projection, room, time window, alert/action result, excursion, and affected-batch impact review.

**Acceptance evidence:** Tests must link environmental excursions to active batches and require disposition review.

### 8. Deviation Intake Taxonomy

**Justification:** Deviations differ by process, equipment, material, documentation, lab, contamination, mix-up, and data integrity causes.

**Improvement:** Expand `deviation` with category, severity, detection point, impacted batch, containment action, immediate correction, investigation owner, and due date.

**Acceptance evidence:** Tests must open and classify deviations from batch execution, testing, material, and equipment evidence.

### 9. Root Cause Analysis

**Justification:** Deviation closure without root cause discipline leads to recurrence.

**Improvement:** Add root cause method, hypotheses, evidence, confirmed cause, contributing factors, recurrence risk, and reviewer approval.

**Acceptance evidence:** Tests must block major deviation closure without approved root cause evidence.

### 10. CAPA Lifecycle

**Justification:** CAPA must define corrective action, preventive action, owner, due date, effectiveness, and recurrence monitoring.

**Improvement:** Expand `capa` with action type, source deviation, owner, implementation evidence, effectiveness check, overdue escalation, and closure proof.

**Acceptance evidence:** Tests must prevent CAPA closure without implementation and effectiveness evidence.

### 11. Change Control Linkage

**Justification:** Manufacturing quality changes must be assessed for product, process, validation, training, and regulatory impact.

**Improvement:** Add change reference, impacted records, risk assessment, validation requirement, training need, effective date, and post-change monitoring.

**Acceptance evidence:** Tests must block batch record activation when required change-control evidence is missing.

### 12. Validation Protocol Management

**Justification:** Processes, cleaning, methods, systems, and equipment need approved validation plans and results.

**Improvement:** Expand `validation_protocol` with validation type, objective, acceptance criteria, sample plan, execution steps, deviations, summary, and approval.

**Acceptance evidence:** Tests must execute validation protocols and reject approval when acceptance criteria fail.

### 13. Continued Process Verification

**Justification:** Validated processes must remain in control over time.

**Improvement:** Add CPV metrics, control limits, trend rules, batch cohorts, signal detection, review state, and action recommendation.

**Acceptance evidence:** Tests must detect process drift and open review tasks with supporting batch evidence.

### 14. Cleaning Verification and Hold Times

**Justification:** Cross-contamination risk depends on cleaning evidence and dirty/clean hold times.

**Improvement:** Add cleaning status, residue limits, swab/rinse results, dirty hold, clean hold, expiry, and affected equipment train.

**Acceptance evidence:** Tests must block batch start when cleaning status or hold time is invalid.

### 15. Contamination and Mix-Up Controls

**Justification:** Product mix-up and contamination are high-severity manufacturing risks.

**Improvement:** Add line clearance checklist, label reconciliation, material segregation, area status, contamination signal, and quarantine action.

**Acceptance evidence:** Tests must open high-severity deviations for failed line clearance or label reconciliation.

### 16. Batch Genealogy and Traceability

**Justification:** Finished goods must trace back to materials, process steps, tests, equipment, operators, and packaging.

**Improvement:** Build genealogy projection linking batch, intermediate, materials, equipment, test results, deviations, CAPA, and serialization events.

**Acceptance evidence:** Replay tests must reconstruct genealogy idempotently and support recall impact analysis.

### 17. Serialization Event Control

**Justification:** Serialized product events support anti-counterfeit controls and distribution traceability.

**Improvement:** Expand `serialization_event` with serial, aggregation, deaggregation, commission, pack, ship, decommission, exception, and destination projection.

**Acceptance evidence:** Tests must reject duplicate active serials and preserve event order.

### 18. Batch Release Checklist

**Justification:** Release requires complete batch record, testing, deviations, CAPA impact, labels, serialization, and quality approval.

**Improvement:** Expand `batch_release` with required evidence checklist, quality reviewer, conditional release, rejection reason, and release certificate.

**Acceptance evidence:** Tests must block release when deviations, tests, or serialization evidence are unresolved.

### 19. Quarantine and Disposition

**Justification:** Materials, intermediates, and finished goods need controlled quarantine, reject, rework, release, or destroy decisions.

**Improvement:** Add disposition state, reason, authority, affected quantity, hold location, rework instruction, destruction evidence, and event emission.

**Acceptance evidence:** Tests must prevent unauthorized disposition and preserve quantity reconciliation.

### 20. Stability Program Integration

**Justification:** Stability failures can affect release, shelf life, and marketed product.

**Improvement:** Add stability protocol projection, sample pull, test result, trend, out-of-spec event, and affected batch review.

**Acceptance evidence:** Tests must open quality review for failing or trending stability results.

### 21. Out-of-Spec and Out-of-Trend Handling

**Justification:** Laboratory exceptions require structured investigation and batch impact assessment.

**Improvement:** Add OOS/OOT case, hypothesis, retest plan, invalidation evidence, confirmed result, product impact, and closure decision.

**Acceptance evidence:** Tests must block release while related OOS/OOT cases are open.

### 22. Supplier Quality Event Linkage

**Justification:** Supplier complaints and material defects can affect batches.

**Improvement:** Add supplier event projection, affected material lots, supplier response, quality agreement obligation, and batch impact.

**Acceptance evidence:** Tests must identify batches affected by supplier quality events without owning supplier master data.

### 23. Training and Qualification Gates

**Justification:** Operators must be trained and qualified for procedures before execution.

**Improvement:** Add training requirement projection, qualification status, expiry, task scope, and batch-step gate.

**Acceptance evidence:** Tests must reject execution or verification by unqualified users.

### 24. Document Control for Quality Records

**Justification:** Procedures, specifications, protocols, and forms must be controlled and versioned.

**Improvement:** Add document type, version, approval, effective date, retired date, linked batches, and read-and-understood evidence.

**Acceptance evidence:** Tests must block use of obsolete documents in new batch execution.

### 25. Data Integrity Controls

**Justification:** Regulated manufacturing must prevent backdating, unauthorized changes, missing audit trails, and orphan records.

**Improvement:** Add controls for timestamp order, actor authorization, source checksum, required e-signatures, missing reason-for-change, and duplicate records.

**Acceptance evidence:** Tests must open data-integrity exceptions and require remediation evidence.

### 26. Deviation and CAPA Workbench

**Justification:** Quality teams need queues by severity, overdue status, product impact, and release blocker.

**Improvement:** Add workbench views for open deviations, release blockers, overdue CAPA, recurrence, data integrity issues, validation blockers, and batch release readiness.

**Acceptance evidence:** UI tests must prove views map to owned data and permission-aware actions.

### 27. Agent-Assisted Quality Narratives

**Justification:** Investigations need clear narratives, but quality conclusions must be evidence-cited.

**Improvement:** Add agent skills for deviation summary, root-cause draft, CAPA plan draft, batch release blocker explanation, and validation summary.

**Acceptance evidence:** Tests must require cited evidence and human approval before regulated narratives are finalized.

### 28. Governed Agent CRUD Commands

**Justification:** The chatbot should support quality operations without silent regulated-record changes.

**Improvement:** Add command previews for open deviation, assign investigation, add CAPA, record validation result, hold batch, release batch, and create serialization exception.

**Acceptance evidence:** Intent tests must require record identity, evidence, preview, confirmation, e-signature where required, and audit trail.

### 29. Quality Risk Management

**Justification:** Batch and process decisions require documented severity, occurrence, detectability, and mitigation.

**Improvement:** Add risk assessments tied to deviations, changes, validations, release, supplier events, and process trends.

**Acceptance evidence:** Tests must require risk review for major deviations and high-impact changes.

### 30. Recall Impact Analysis

**Justification:** Recall decisions require rapid identification of affected batches, lots, serials, destinations, and quality causes.

**Improvement:** Add recall candidate analysis from genealogy, serialization, deviations, stability, complaints, and distribution projections.

**Acceptance evidence:** Tests must generate affected-batch lists and recall evidence packets without owning distribution tables.

### 31. Product Complaint Linkage

**Justification:** Market complaints can reveal manufacturing defects or stability issues.

**Improvement:** Add complaint projection, defect category, affected batch, investigation link, trend, reportability assessment, and CAPA trigger.

**Acceptance evidence:** Tests must open investigations for serious or recurring complaints.

### 32. Regulatory Inspection Evidence Room

**Justification:** Inspectors need controlled evidence for batches, deviations, CAPA, validation, training, and data integrity.

**Improvement:** Add evidence room generation by product, batch, site, date range, deviation, validation, or control.

**Acceptance evidence:** Tests must generate scoped, redacted, source-linked evidence packets.

### 33. Multi-Site and Tech Transfer Controls

**Justification:** Process transfer requires comparability, validation, training, and site-specific controls.

**Improvement:** Add site variant, transfer protocol, comparability evidence, local adaptation, validation requirement, and launch readiness.

**Acceptance evidence:** Tests must block site activation for product manufacturing until transfer criteria pass.

### 34. Packaging and Label Reconciliation

**Justification:** Packaging errors can cause recalls and patient harm.

**Improvement:** Add packaging line clearance, label count, reconciliation variance, artwork version, expiry print check, and destruction evidence.

**Acceptance evidence:** Tests must open deviations for unreconciled label variances or wrong artwork version.

### 35. Hold Time and Expiry Controls

**Justification:** Intermediates, bulk product, and packaging stages have hold-time limits.

**Improvement:** Add hold-time start, limit, storage condition, extension approval, expiry breach, and disposition impact.

**Acceptance evidence:** Tests must block continuation or release when hold time expires without approval.

### 36. Quality Metrics and Management Review

**Justification:** Leadership needs metrics for deviations, CAPA, batch release, right-first-time, complaints, recalls, validation, and data integrity.

**Improvement:** Add metrics with definitions, numerator/denominator, trend, threshold, source, and management review action.

**Acceptance evidence:** Tests must compute metrics and open actions when thresholds are breached.

### 37. Predictive Batch Release Risk

**Justification:** Teams need early warning before a batch becomes unreleasable or delayed.

**Improvement:** Add explainable risk scoring from deviations, test status, process parameters, equipment evidence, genealogy, and historical patterns.

**Acceptance evidence:** Tests must generate risk factors and require human review for automated recommendations.

### 38. Configuration Impact Simulation

**Justification:** Changing specifications, process parameters, hold times, or release rules can affect many batches.

**Improvement:** Add side-effect-free simulations over historical and active batches with release, deviation, workload, and compliance impact.

**Acceptance evidence:** Tests must require impact evidence before activating high-risk configuration.

### 39. Cross-PBC Boundary Proofs

**Justification:** Manufacturing quality composes with inventory, LIMS, EAM, suppliers, distribution, audit, and finance without table sharing.

**Improvement:** Add release gates proving dependencies use declared APIs, events, projections, or package metadata.

**Acceptance evidence:** Tests must fail on undeclared foreign table references and pass on AppGen-X contracts.

### 40. Electronic Signature Meaning

**Justification:** Regulated records need signatures with purpose, authority, and linked state change.

**Improvement:** Add e-signature purpose for execution, verification, review, approval, rejection, release, and correction.

**Acceptance evidence:** Tests must reject signatures by unauthorized roles and preserve signature meaning.

### 41. Audit Trail Review

**Justification:** Audit trails must be reviewed for critical records and suspicious changes.

**Improvement:** Add audit review schedules, reviewed record sets, exceptions, reviewer, finding, and remediation.

**Acceptance evidence:** Tests must identify unreviewed required audit trails and open control failures.

### 42. Cryptographic Batch Evidence Proofs

**Justification:** Batch and quality history needs tamper-evident proof.

**Improvement:** Add hash chains for batch execution, material genealogy, deviations, CAPA, validation, release, and serialization events.

**Acceptance evidence:** Tests must verify proof chains and detect altered payloads or reordered events.

### 43. Dead-Letter and Retry Operations

**Justification:** Batch events, lab results, serialization events, and audit records can fail and need safe replay.

**Improvement:** Add retry reason, risk, idempotency key, replay checkpoint, remediation action, and dead-letter queue.

**Acceptance evidence:** Tests must replay failed events without duplicate deviations, releases, or serial events.

### 44. Carbon and Resource Awareness

**Justification:** Manufacturing quality can reduce waste from rework, scrap, reruns, cold storage, and excessive holds.

**Improvement:** Add optional resource metrics for rejected quantity, rework, scrap, energy-intensive holds, sample reruns, and disposal category.

**Acceptance evidence:** Tests must report resource metrics without overriding quality or safety decisions.

### 45. Seeded Pharma Quality Scenario Library

**Justification:** Release audits need realistic regulated manufacturing stories.

**Improvement:** Add seeds for clean batch, process deviation, material defect, OOS, CAPA, validation failure, label reconciliation issue, serialization exception, and batch release.

**Acceptance evidence:** Scenario tests must load side-effect-free and create expected queues, events, and evidence packets.

### 46. Role-Based Permission Model

**Justification:** Operators, supervisors, QA reviewers, validation engineers, release approvers, and auditors need different authority.

**Improvement:** Add permissions for execute step, verify step, open deviation, approve CAPA, approve validation, release batch, dispose material, and view audit packets.

**Acceptance evidence:** Permission tests must block unauthorized commands and show disabled UI actions.

### 47. Regulatory Localization

**Justification:** Manufacturing quality requirements vary by product, market, site, and regulatory region.

**Improvement:** Add jurisdiction-specific release, retention, reportability, serialization, documentation, and signature rules.

**Acceptance evidence:** Tests must evaluate identical events differently by jurisdiction and policy version.

### 48. Full Pharma Quality Release Simulation

**Justification:** A complete PBC must prove batch-quality behavior end to end.

**Improvement:** Add a simulation where a batch starts, materials issue, steps execute, in-process tests pass, a deviation opens, CAPA completes, serialization records, and QA releases the batch.

**Acceptance evidence:** The simulation must validate owned schema, APIs, services, AppGen-X events, handlers, workbench views, agent skills, permissions, and release evidence.

### 49. Package Overlap Guardrails

**Justification:** This PBC must not duplicate LIMS, inventory, EAM, supplier, distribution, finance, or regulatory submission ownership.

**Improvement:** Add overlap checks and declared dependency contracts for lab results, material status, equipment state, supplier quality, distribution trace, and audit events.

**Acceptance evidence:** Tests must fail on undeclared external table references and pass on declared AppGen-X dependency usage.

### 50. Composition DSL and Unified Agent Exposure

**Justification:** Generated applications must expose pharma quality capabilities through DSL, UI, APIs, and the composed application agent.

**Improvement:** Extend composition metadata for batches, master records, validation, deviations, CAPA, release, serialization, controls, evidence rooms, workbench fragments, and agent skills.

**Acceptance evidence:** DSL tests must prove generated apps include pharma quality models, routes, services, event contracts, UI artifacts, and assistant skills without stream-engine picker exposure.
